{
  "id": 1542,
  "text": "# 13.3 Development group comments There was uniform agreement in the development group based on level 1 evidence (meta-analyses and phase III chemoradiotherapy trials) that combined chemoradiotherapy and brachytherapy is the method of choice for the management of stage T2b-T4a cervical cancer and also for stage T1b2/T2a2 with involved LNs on radiological staging (iN1).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # 13.3 Development group comments There was uniform agreement in the development group based on level 1 evidence (meta-analyses and phase III chemoradiotherapy trials) that combined chemoradiotherapy and brachytherapy is the method of choice for the management of stage T2b-T4a cervical cancer and also for stage T1b2/T2a2 with involved LNs on radiological staging (iN1).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于T2b到T4a阶段的宫颈癌，以及在放射学分期中发现淋巴结受累的T1b2/T2a2病例，首选的治疗方法是同步化疗联合放疗（包括近距离治疗）。这一方案基于一级证据（包括荟萃分析和III期同步化疗放疗试验），被认为是治疗这些阶段宫颈癌的标准方法。此综合治疗手段旨在提高肿瘤控制率和患者生存率，同时最大限度减少肿瘤复发的风险。",
  "query": "对于T2b到T4a阶段的宫颈癌，以及在放射学分期中发现淋巴结受累的T1b2/T2a2病例，哪种治疗方案被认为是首选方法？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于T2b到T4a阶段的宫颈癌，以及在放射学分期中发现淋巴结受累的T1b2/T2a2病例，哪种治疗方案被认为是首选方法？\n\n<reference text>: # 13.3 Development group comments There was uniform agreement in the development group based on level 1 evidence (meta-analyses and phase III chemoradiotherapy trials) that combined chemoradiotherapy and brachytherapy is the method of choice for the management of stage T2b-T4a cervical cancer and also for stage T1b2/T2a2 with involved LNs on radiological staging (iN1).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于T2b到T4a阶段的宫颈癌，以及在放射学分期中发现淋巴结受累的T1b2/T2a2病例，首选的治疗方法是同步化疗联合放疗（包括近距离治疗）。这一方案基于一级证据（包括荟萃分析和III期同步化疗放疗试验），被认为是治疗这些阶段宫颈癌的标准方法。此综合治疗手段旨在提高肿瘤控制率和患者生存率，同时最大限度减少肿瘤复发的风险。"
}